James Moreci, MD
Internal Medicine · Myrtle Beach, SCNPI 1982677183
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 262 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 16.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,395 and has fallen 89.2% since, to $150 in 2023.
Across 262 payments — averaging $15.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$634
- Amgen$557
- AbbVie$364
- Antares Pharma, Inc.$337
- Abbott$254
- Novo Nordisk$245
- plus $2K from 26 others
What the payments were for
- Food & beverage$3,965100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 51 | $634 |
| Amgen | 35 | $557 |
| AbbVie(2 entities) | 27 | $364 |
| Antares Pharma, Inc. | 16 | $337 |
| Abbott | 12 | $254 |
| Novo Nordisk | 16 | $245 |
| UCB, Inc. | 14 | $217 |
| Merck | 10 | $183 |
| Lilly USA, LLC | 14 | $171 |
| Sanofi-aventis U.S. LLC | 9 | $125 |
| Amarin Pharma, Inc. | 8 | $114 |
| Currax Pharmaceuticals LLC | 8 | $102 |
| Mallinckrodt Hospital Products Inc. | 6 | $88 |
| Radius Health, Inc. | 4 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $55 |
| Mannkind Corporation | 3 | $47 |
| Pacira Therapeutics, Inc. | 2 | $44 |
| GSK | 2 | $42 |
| AstraZeneca | 3 | $41 |
| Daiichi Sankyo Inc. | 2 | $34 |
| Mallinckrodt Enterprises LLC | 2 | $32 |
| Astellas Pharma US Inc | 2 | $29 |
| Dexcom, Inc. | 2 | $27 |
| Arbor Pharmaceuticals, Inc. | 2 | $26 |
| Boehringer Ingelheim | 1 | $26 |
| Bayer | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Eisai Inc. | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
| Insulet Corporation | 1 | $13 |
| Esperion Therapeutics, Inc. | 1 | $12 |
How this compares
$3,965 in reported general payments places this provider in the 85th percentile of 1,498 internal medicine providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $380 |
| Atorvastatin Calcium | 24 | $302 |
| Pantoprazole Sodium | 28 | $247 |
| Methylprednisolone | 26 | $150 |
| Levothyroxine Sodium | 18 | $118 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $95 |
| Losartan Potassium | 17 | $88 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Myrtle Beach
- Edward Botse-BaidooMyrtle Beach$90K
- Sarah AllenMyrtle Beach$17K
- James IserniaMyrtle Beach$16K
- Jerry BackNorth Charleston$322K
- Jan BasileCharleston$278K
- Mark PurcellGreenville$165K
- John CleekCharleston$136K
- William BunnHilton Head Island$125K
- Zion LammGreenville$118K
- Bruce GrayGreenville$111K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.